Vol. 277, Issue 1, R314-R319, July 1999
Effects on regional brain metabolism of high-altitude hypoxia:
a study of six US marines
P. W.
Hochachka1,
C. M.
Clark2,
G. O.
Matheson3,
W. D.
Brown4,
C. K.
Stone4,
R. J.
Nickles4, and
J. E.
Holden4
1 Department of Zoology and
Sports Medicine Division and
2 Department of Psychiatry,
University of British Columbia, Vancouver, British Columbia, Canada V6T
1Z4; 3 Department of Functional
Restoration, Stanford University School of Medicine, Stanford,
California 94305-6175; and
4 Department of Medical Physics,
Radiology, and Medicine, University of Wisconsin, Madison,
Wisconsin 53706
 |
ABSTRACT |
Previous studies of brain glucose
metabolism in people indigenous to high-altitude environments uncovered
two response patterns: Quechuas native to the high Andes of South
America sustained modest hypometabolism in most brain regions
interrogated, whereas Sherpas, native to the Himalayas and considered
by many biologists to be most effectively high-altitude adapted of all
humans, showed brain metabolic patterns similar to lowlanders, with no
acclimation effects noted. In the present study, the database was
expanded to include hypoxia acclimation effects in lowlanders. Positron emission tomography (PET) and
[18F]-2-deoxy-2-fluro-D-glucose
(FDG) imaging techniques were used to assess regional cerebral glucose
metabolic rates (rCMRglc) in six
US marines (Caucasian lineage) before and after a 63-day training
program for operations at high altitudes ranging from 10,500 to 20,320 ft. Significant changes in rCMRglc
were found for 7 of 25 brain regions examined. Significant decreases in
absolute cerebral glucose metabolism after high-altitude exposure were found in five regions: three frontal, the left occipital lobe, and the
right thalamus. In contrast, for the right and left cerebellum significant increases in metabolism were found. The magnitudes of these
differences, in terms of absolute metabolism, were large, ranging from
10 to 18%. Although the results may not be solely the result of lower
oxygen levels at high altitude, these findings suggest that the brain
of healthy human lowlanders responds to chronic hypoxia exposure with
precise, region-specific fine tuning of
rCMRglc. The observed short-term
hypoxia acclimation responses in these lowlanders clearly differ from
the long-term hypoxia adaptations found in brain metabolism of people
indigenous to high-altitude environments.
brain positron emission tomography; hypobaric hypoxia; hypoxia
acclimation; brain glucose metabolism
 |
INTRODUCTION |
FOR THE PAST DECADE, we have been examining the effects
of hypobaric hypoxia on regional cerebral glucose metabolic rates (rCMRglc) in humans. In our
first study, we assessed rCMRglc
in Quechuas living at high altitude in the Andes (11). On their arrival
at sea level, rCMRglc was
depressed relative to rCMRglc in
lowlanders. Reductions were most evident in frontal cortex and the
angular gyrus. After acclimating for 3 wk to sea level normoxia,
rCMRglc changed modestly but still
did not fall within the lowlander range. Later studies with Sherpas
from the Himalayas, a group living at high altitude for a longer period
than the Quechuas, showed regional patterns and
rCMRglc similar to lowland
normals. Moreover, these values of
rCMRglc were unchanged after 3 wk
of low-altitude acclimation (13). Our
rCMRglc findings were consistent with medical studies of the Sherpas, reporting an absence of symptoms that are typically associated with hypobaric hypoxia exposure in
lowlanders (5, 6). Therefore we interpreted these data to indicate
that, probably due to longer time, the Sherpas expressed a more
complete metabolic adaptation than the Quechuas. If this hypothesis is
correct, one would anticipate that lowlanders exposed to high altitudes
for an extended time period may exhibit major changes in brain metabolism.
The opportunity to test this hypothesis arose when a US Marine training
center in California agreed to provide six volunteers before and after
a 63-day high-altitude training program. Because we were relying on the
largess of the US Marine Corp, we could not control for confounding
factors such as nutrition, training regimen, and travel stress.
However, given the logistics, ethical concerns, and expense of such a
study, we decided to take advantage of the opportunity. We found that
after the prolonged high-altitude exposure the brain's metabolic
patterns changed significantly, with five regions having significant
decreases in metabolism and two regions having significant increases in
rCMRglc. Although we
used each individual as his own control (pretraining vs. posttraining comparisons) and were not able to include a control group who experienced similar conditions with the exception of high-altitude exposure, the magnitude of the changes and the bidirectionality are
completely inconsistent with changes associated with test/retest studies of rCMRglc (34). Thus we
tentatively conclude that the effects that we observed are largely or
solely due to prolonged exposure to hypobaric hypoxia.
 |
METHODS |
Subjects. The subjects for the present
study were six male US marines of Caucasian (European) ancestry
stationed at a training center in California (altitude ~6,000 ft).
Their mean age was 29.7 yr (SD = 3.6 yr, range 23.0-33.0). Before
the program started, all six subjects were exercise tested using
bicycle ergometry (Table 1). The group then
underwent an extensive training period for high-altitude operations at
three different sites, ranging from ~10,500 to 14,400 ft. After this
training, they successfully reached the 20,320-ft summit of Denali
(also known as Mt. McKinley, AK) over a 16-day period. The total time
of high-altitude training and scaling the summit of Denali was 63 days.
Brain metabolic features of all subjects were assessed before training
and 1 day after the descent of Denali. For these positron emission
tomography (PET) assessments, the subjects were admitted as inpatients
to the University of Wisconsin General Clinical Research Center. Medical and neurological examinations were negative before and after
high-altitude exposure. On completion of the brain PET studies, a
number of exercise parameters were again determined and none were found
to have changed drastically throughout the 63-day program. Most
significantly, the average body weight was unchanged at ~80 kg, and
the maximum aerobic metabolic rate
(
O2 max) tended to increase, but the values also were statistically similar before and
after the high-altitude program (~50 ml
O2 · kg
1 · min
1)
(Table 1). The
O2 max
values in fact are similar to those for other mountaineers (16, 20).
All experimental procedures were approved by the Human Ethics
Committees at the Universities of British Columbia and Wisconsin.
Informed consent was obtained for all nonmilitary aspects of this
study.
PET scanning. After an overnight fast,
a venous cannula was placed in the left antecubital vein and a right
hand vein. The right hand was placed in a warming device to induce
hyperemia. Blood samples taken from this hand were considered to be
adequately representative of arterial blood.
[18F]-2-deoxy-2-fluro-D-glucose
(FDG; 7 mCi) was injected into the antecubital cannula as a bolus, and
blood samples were taken at a progressively decreasing rate from the
right hand over the next 70 min. A dynamic study of myocardial uptake
(data not shown) was performed during the next 46-min
uptake period. The subject was then positioned for brain imaging in a
GE advanced positron tomograph (GE Medical Systems, Waukesha, WI) at
the Wisconsin PET Imaging Center. The 14.4-cm axial field of view was
positioned to encompass the entire cerebrum and cerebellum. Image data
were acquired for 30 min in conventional 2-D mode followed by a 10-min transmission scan using the postemission mode offered by the
manufacturer. Transmission data were used to correct the emission data
for attenuation. The time course of radioactivity in plasma was derived
from the blood sample sequence using conventional counting techniques. Additional blood samples were used to determine the plasma glucose concentrations at three time points over the course of the procedure. Plasma metabolite concentrations were determined using standard clinical chemistry laboratory methods. Plasma glucose concentrations were stable under both study conditions, 5.13 and 5.03 µmol/ml of
plasma, respectively.
The acquired maps of radioactivity concentration were converted pixel
by pixel to glucose uptake rates using the Sokoloff et al. equation
(33) as modified by Huang et al. (19). Standard gray matter rate
constants (31) and a lumped constant of 0.48 were used. Regional
estimates for 25 cortical and subcortical areas were derived by
visually placing circular regions of interest (ROI; area = 1.1 cm2 in a single axial plane; 4.25 mm axial plane separation) to conform to a standard PET template of
neuroanatomical structures. The rCMRglc estimates for the 25 ROIs
were averaged over subjects. The changes in mean metabolic rate for
each region pre- and posttraining were compared using a paired
t-test.
 |
RESULTS |
The means, SD, and resulting t-values
for the 25 ROIs are given in Table 2, with
illustrative PET images presented in Fig. 1. For five regions, significant decreases
in rCMRglc were found, whereas for
two regions, the right and left cerebellum, significant increases were
observed. The rCMRglc values for
most other regions seemed the same in pre- and postacclimatization
states. The total number of significant differences (7 of 25)
significantly exceeded chance expectancy, whereas the fact that some
regions increased while others decreased means that the findings are
not the result of statistical artifact or scalar drift. For the five
regions where decreases were observed, three were in frontal cortex
[average change 11.1, 7.4, and 10.5%, respectively (Table 2;
Fig. 1)]. In addition, the left occipital cortex sustained an
average decrease in rCMRglc of
9.0%, whereas the right thalamus sustained a 16.9% decrease. The left
thalamus also displayed a decrease in
rCMRglc, but this change only
approached the accepted statistical significance level
(P < 0.1). In contrast to the other
brain regions, the cerebellum sustained a significant increase in
rCMRglc. For the right and left
cerebellum, the increases were 17.8 and 16.6%, respectively (Table 2).
View this table:
[in this window]
[in a new window]
|
Table 2.
Mean rCMRglc with difference and resulting t-values
for 25 ROIs before and after hypobaric hypoxia acclimatization
|
|

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 1.
Representative positron emission tomography (PET) images of regional
cerebral glucose metabolic rate
(rCMRglc) in an individual
subject pre- and postacclimation to high-altitude regimen. Color coding
(red through yellow to green) covers an
rCMRglc range from ~0.6 to 0.3 µmol
glucose · g 1 · min 1.
|
|
 |
DISCUSSION |
One of the main problems with many studies of humans at high altitude
is that it is frequently impossible to isolate hypobaric hypoxia as the
only variable parameter. In our case, for example, we were unable to
rigorously control nutritional intake, exercise training regimen, and,
in final stages of the program, any metabolic artifacts due to air
travel. However we feel that these factors did not contribute to
observed pre- and postexposure brain metabolic differences for several
reasons. In the first place, it is worth emphasizing that air travel
preceded both sets of PET measurements and moreover that all subjects
underwent medical examination on arrival and on departure from the
General Clinical Research Center. No problems or differences between
the first and second visits were noted and an impression of fit
individuals, all in good health, predominated our discussion with the
medical personnel performing these examinations. Second, during the
actual 63-day training for altitude operations these subjects were
"on duty" in a professional organization with an interest in
maintaining factors such as fitness, physical training regimens, and
nutritional status at constant high levels. That is why we anticipated,
and indeed found, that there were essentially no statistically
significant changes in several physical and physiological parameters
measured before and after the 63-day high-altitude program (Table 1).
When measured at sea level, there were modest or no effects on body
weight, blood pressure, maximum exercise-induced heart rate, maximum
respiration rate, tidal volume, or maximum ventilation. The modestly
higher
O2 max
and exercise times to fatigue observed after the 63-day high-altitude
program are consistent with the work of others on high-altitude effects
on exercise (see Refs. 16 and 20 for more literature on hypoxia
exposure and exercise capacities). These data persuade us that
parameters such as nutrition and exercise training regimens did not
introduce significant artifacts to our data. Thus we assume that, as in
many other studies of this type (16, 20, 28, 29), the dominant
environmental parameter that differed in the two states we examined was
the long exposure to hypobaric hypoxia. Any effects of the 63-day
program presumably would be predominantly due to hypobaric hypoxia. We
therefore tentatively conclude that in lowlanders of Caucasian lineages the acclimation response of the central nervous system to prolonged exposure to high-altitude hypoxia is complex and includes stabilizing rCMRglc in many regions of the
brain, decreasing rCMRglc in five regions of the brain (the frontal cortex, the left occipital cortex, and the thalamus), and increasing
rCMRglc in a few other specific regions (especially the cerebellum).
Unfortunately there are few studies of hypoxia acclimation effects on
mammalian brain against which to compare these results. In rats,
hypoxia acclimation has been shown to lead to a global increase in
glucose uptake and metabolism (7, 8, 23), but the metabolic data from
the rat studies were collected while the animals were in the hypoxic
state. Although there was a 20% increase in
rCMRglc during the sustained
hypoxia (e.g., Ref. 8), there could well have been a decrease in
rCMRglc when the animals were
returned to normoxia for the FDG uptake measurements. In fact there are
indirect indications of downregulation of cerebral energy metabolism in
rats after hypoxia acclimation. For example, hypoxia acclimation is
associated with depressed cytochrome oxidase activity in both rat (22)
and mouse (2) brain, and decreased neutrophil mitochondrial volume
densities have been noted (35). LaManna and coworkers (21, 24) also
have proposed that small changes in
rCMRglc may represent changes in
the ratio of glycolytic to oxidative pathways that serve to balance
tissue acid-base balance induced by the ventilatory response to
hypoxia. The hypothesis proposes that ventilatory-induced mild
alkalosis is reversed by glycolysis-associated
H+ production to restore tissue
intracellular pH balance. This hypothesis probably does not apply to
our data in this study, because our PET measurements were done under
normoxic conditions with no hyperventilation-induced alkalosis, nor to
our knowledge are there any other data that would bear directly on this
issue in human brain metabolism. In fact, given the large interest in
human hypoxia responses, the dearth of studies of hypoxia effects on
rCMRglc in humans is surprising. To be sure, Cohen et al. (4) did examine the effects of hypoxia on
total brain metabolic rates, but perhaps because their work predated
the advent of the PET/FDG technique, they found no differences in
hypoxic vs. normoxic states. However, they posited the possibility of
regional adjustments in rCMRglc.
Interestingly our findings are consistent with their speculation. Other
studies of region-specific metabolic rates in the brain of humans have
been directed to issues other than hypoxia acclimation (for examples,
see Refs. 5, 6, 19, 31, 34).
An important issue that requires explanation is the magnitude of
rCMRglc differences, both region
specific and due to high-altitude acclimatization. If we assume that
essentially all of the glucose metabolized is fully oxidized, yielding
36 mol ATP/mol glucose, then in region-by-region comparisons, the left
frontal cortex displays the highest metabolic rates noted (23.0 µmol
ATP · g
1 · min
1),
whereas the lowest rCMRglc was
observed in the left cerebellum (14.8 µmol
ATP · g
1 · min
1).
After high-altitude acclimatization, the metabolic rate in the left
frontal cortex decreased from 23.0 to 19.1 µmol
ATP · g
1 · min
1,
whereas the left cerebellum increased from 14.8 to 17.6 µmol ATP · g
1 · min
1.
To remain in energy balance, ATP demand or energetic efficiency (or a
combination of both) presumably had to change by equivalent amounts.
These are substantial shifts in energy supply; for reference, it may be
worth mentioning that resting muscle turns over ATP at ~1 µmol
ATP · g
1 · min
1
(16, 26).
With completion of these studies, firm databases are now established on
human brain metabolic organization in three different human lineages,
each varying in historical adaptation to hypoxia. Comparative
biochemists have long appreciated the interplay between evolutionary
time and adaptational options: the longer the time available the more
profound or complete the adaptive response (9, 10, 14, 20). Thus it is
not surprising that many workers in this field explicitly or implicitly
consider Sherpas to be most exquisitely high-altitude adapted of all
human lineages, they have been indigenous to high altitude for
millennia (12, 14, 28, 29). The Quechuas are presumed to have been
living in high-altitude environments for intermediate time periods (28, 29), and of course the lowlanders used in the present study represent
about a 9-wk acclimatization to hypobaric hypoxia. A recent analysis of
the evolution of hypoxia tolerance in our species (14) points out that
the last time the Quechuas and Sherpas shared a common ancestor was a
very long time ago, about one-third the age of our species, and the
last time Europeans shared ancestors with both highlander groups was
even further back in our phylogenetic history. In terms of
rCMRglc, Sherpas appear to show
the fullest degree or most complete form of metabolic adaptation, i.e.,
comparable to normoxic lowlanders (13). The dominant brain metabolic
defense strategy in the Quechuas (11) appears to be a mild suppression of rCMRglc, presumably coincident
with mild suppression of various energy-demanding processes (9, 10, 15,
25, 32). The lowlanders in the present study seem to represent an
intermediate pattern of defense against chronic hypoxia, with
rCMRglc increasing, decreasing, or
unchanging, depending on the brain region being interrogated.
Parenthetically, it should be noted that the two earlier studies of
Sherpas and Quechuas were done on a different PET scanner than the
current study; although comparisons of relative patterns within each
study series are valid, direct comparisons of absolute rates between
the two groups of studies are not.
Perspectives
To physiologists, the fundamental question remaining concerns the
functional consequences or physiological meaning of the stable
rCMRglc adjustments observed
during hypoxia acclimation of lowlanders. It certainly would not be
unreasonable to anticipate some functional consequences given the
magnitude of rCMRglc
adjustments noted above. In this regard, it is worth noting that the
often-observed abnormal behavior and/or poor judgment of mountaineers
in extreme hypobaric hypoxic conditions (36) is consistent with the
hypothesized functional specialization of the frontal cortex, an area
where we found reduced metabolic rates. At the same time, in addition to the hypobaric hypoxia, the subjects in this study also were in a
situation where learning and practicing new tasks was part and parcel
of the assignment. An anonymous reviewer suggested that the increased
rCMRglc in the cerebellum and
thalamus might be correlated with the learning and practicing of new
activities (30). Although this is an interesting possibility, it is
important to recall that our PET data were acquired in the resting
state, whereas Petersen et al. (30) were doing functional activation tests and acquired their data while the subjects were doing specific tasks.
To evolutionary biologists familiar with numerous molecular and
metabolic defense mechanisms that have evolved in hypoxia-tolerant species through phylogenetic time to protect cells and tissues against
oxygen limitation (9, 10, 14, 15, 25, 32), the issues are somewhat
different. To these workers, it would be particularly interesting if
the observed changes in metabolic organization of the human brain after
hypoxia acclimatization of lowlanders were in any way advantageous or
"protective" against hypoxia. Unfortunately our data cannot be
simply interpreted this way. Indeed, if our above speculation regarding
frontal cortex function is correct, any such biologically protective
mechanisms may not be behaviorally adaptive in the short run. Although
further work is required to probe the issue of adaptive significance of rCMRglc adjustments during
prolonged hypoxia exposure, it is tempting to consider that it is the
phylogenetically "older" portion of the human brain, the
so-called mammalian/reptilian brain, not the human species-specific
neocortex (frontal lobe), that may be the region preferentially
"protected" during hypoxia acclimation, because it is the region
that sustains an elevated rCMRglc
during week-long hypoxic exposure. That is, the coordination of basic biological functions such as locomotor abilities may supercede the more
advanced neurological functions normally ascribed to the frontal cortex.
In any event, the fundamental insight that derives from these studies
is that the brain of healthy human lowlanders responds to chronic
hypoxia exposure with precise, region-specific fine tuning of
rCMRglc: downregulation occurs in
the frontal cortical regions, whereas upregulation occurs in the
cerebellum. Most other regions sustain stable metabolism even after
prolonged acclimation to hypobaric hypoxia. Interestingly, rather
striking region-specific metabolic responses to acute hypoxia in the
rat brain already are known (27), but to our knowledge no one has yet
applied late 20th century technology to the region-by-region monitoring of metabolic responses to acute hypoxia in the human brain.
 |
ACKNOWLEDGEMENTS |
Our special thanks are due our friends and colleagues from the US
Marines, who fine tuned the meaning of high adventure and high altitude
for the rest of us.
 |
FOOTNOTES |
Our work was supported by National Sciences and Engineering Research
Council (Canada) Operating and Collaborative Grants, by grants from the
Vancouver Foundation (British Columbia), by the Physiology and Behavior
Program, National Science Foundation (USA), and by Grant MOI-RR-03186
from the General Clinical Research Centers Program, National Center for
Research Resources, National Institutes of Health (USA).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: P. W. Hochachka,
Dept. of Zoology, University of British Columbia, 6270 University
Blvd., Vancouver, BC, Canada V6T 1Z4 (E-mail:
pwh{at}zoology.ubc.ca).
Received 16 July 1998; accepted in final form 15 March 1999.
 |
REFERENCES |
1.
Allen, P. S.,
G. O. Matheson,
G. Zhu,
D. Gheorgiu,
R. S. Dunlop,
T. Falconer,
C. Stanley,
and
P. W. Hochachka.
Simultaneous 31P MRS of the soleus and gastrocnemius in Sherpas during graded calf muscle exercise.
Am. J. Physiol.
273 (Regulatory Integrative Comp. Physiol. 42):
R999-R1005,
1997[Abstract/Free Full Text].
2.
Chavez, J. C.,
P. Pichiule,
J. Boero,
and
A. Arregui.
Reduced mitochondrial respiration in mouse cerebral cortex during chronic hypoxia.
Neurosci. Lett.
193:
169-172,
1995[Medline].
3.
Clark, C. M.,
E. W. Growchowski,
and
W. Ammann.
A method for comparing different procedures of estimating regional glucose metabolism using fluorine-18 fluorodeoxyglucose.
J. Nucl. Med.
33:
157-160,
1992[Abstract/Free Full Text].
4.
Cohen, P. J.,
S. C. Alexander,
T. C. Smith,
M. Reivich,
and
H. Wollman.
Effects of hypoxia and normocarbia on cerebral blood flow and metabolism in conscious man.
J. Appl. Physiol.
23:
183-189,
1967[Free Full Text].
5.
Garrido, E.,
A. Castillo,
J. L. Ventura,
A. Capdevilla,
and
F. A. Rodriguez.
Cortical atrophy and other brain MRI changes after extremely high altitude climbs without oxygen.
Int. J. Sports Med.
14:
232-234,
1993[Medline].
6.
Garrido, E.,
R. Segura,
A. Capdevilla,
J. Pujol,
C. Javierre,
and
J. Li Ventura.
Are Himalayan Sherpas better protected against brain damage associated with extreme altitude climbs?
Clin. Sci. (Colch.)
90:
81-85,
1996[Medline].
7.
Harik, S. I.,
R. A. Behmand,
and
J. C. La Manna.
Hypoxia increases glucose transport at the blood-brain barrier.
J. Appl. Physiol.
77:
896-901,
1994[Abstract/Free Full Text].
8.
Harik, S. I.,
W. D. Lust,
S. C. Jones,
K. L. Lauro,
S. Pundik,
and
J. C. La Manna.
Brain glucose metabolism in hypobaric hypoxia.
J. Appl. Physiol.
79:
136-140,
1995[Abstract/Free Full Text].
9.
Hochachka, P. W.
Defense strategies against hypoxia and hypothermia.
Science
231:
234-237,
1986[Abstract/Free Full Text].
10.
Hochachka, P. W.,
L. T. Buck,
C. J. Doll,
and
S. C. Land.
Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack.
Proc. Natl. Acad. Sci. USA
93:
9493-9498,
1996[Abstract/Free Full Text].
11.
Hochachka, P. W.,
C. M. Clark,
W. D. Brown,
C. Stanely,
C. K. Stone,
R. J. Nickles,
G. G. Zhu,
P. S. Allen,
and
J. E. Holden.
The brain at high altitude: hypometabolism as a defense against chronic hypoxia?
J. Cereb. Blood Flow Metab.
14:
671-679,
1994[Medline].
12.
Hochachka, P. W.,
C. M. Clark,
J. E. Holden,
C. Stanley,
K. Ugurbil,
and
R. S. Menon.
31P magnetic resonance spectroscopy of the Sherpa heart: a PCR/ATP signature of metabolic defense against hypobaric hypoxia.
Proc. Natl. Acad. Sci. USA
93:
1215-1220,
1996[Abstract/Free Full Text].
13.
Hochachka, P. W.,
C. M. Clark,
C. Monge,
C. Stanley,
W. D. Brown,
C. K. Stone,
R. J. Nickles,
and
J. E. Holden.
Sherpa brain glucose metabolism and defense adaptations against chronic hypoxia.
J. Appl. Physiol.
81:
1355-1361,
1996[Abstract/Free Full Text].
14.
Hochachka, P. W.,
H. C. Gunga,
and
K. Kirsch.
Our ancestral physiological phenotype: an adaptation for hypoxia tolerance and for endurance performance?
Proc. Natl. Acad. Sci. USA
95:
1915-1921,
1998[Abstract/Free Full Text].
15.
Hochachka, P. W.,
and
G. N. Somero.
Biochemical Adaptation. Princeton, NJ: Princeton Univ. Press, 1984, p. 1-537.
16.
Hochachka, P. W.,
C. Stanley,
G. O. Matheson,
D. C. McKenzie,
P. S. Allen,
and
W. S. Parkhouse.
Metabolic and work efficiencies during exercise in Andean natives.
J. Appl. Physiol.
70:
1720-1729,
1991[Abstract/Free Full Text].
17.
Holden, J. E.,
K. Mori,
G. A. Dienel,
N. F. Cruz,
T. Nelson,
and
L. Sokoloff.
Modeling the dependence of hexose distribution volumes in brain on plasma glucose concentration: implications for estimation of the local 2-deoxyglucose lumped constant.
J. Cereb. Blood Flow Metab.
11:
171-182,
1991[Medline].
18.
Holden, J. E.,
C. Stone,
W. D. Brown,
R. J. Nickles,
C. Stanley,
C. M. Clark,
and
P. W. Hochachka.
Enhanced cardiac metabolism of plasma glucose in high altitude natives. Adaptations against chronic hypoxia.
J. Appl. Physiol.
79:
222-228,
1995[Abstract/Free Full Text].
19.
Huang, S. C.,
M. E. Phelps,
E. J. Hoffman,
K. Sideris,
C. Selin,
and
D. E. Kuhl.
Noninvasive determination of local cerebral metabolic rate of glucose in man.
Am. J. Physiol.
238 (Endocrinol. Metab. 1):
E69-E82,
1980[Abstract/Free Full Text].
20.
Kayser, B.,
H. Hoppler,
H. Classen,
and
P. Cerretelli.
Muscle structure and performance in Himalayan Sherpas.
J. Appl. Physiol.
70:
1938-1942,
1991[Abstract/Free Full Text].
21.
LaManna, J. C.
Hypoxia/ischemia and the pH paradox.
Adv. Exp. Med. Biol.
388:
283-292,
1996[Medline].
22.
LaManna, J. C.,
K. L. Kutina-Nelson,
M. A. Hritz,
Z. Huang,
and
M. T. Wong-Riley.
Decreased rat brain cytochrome oxidase activity after prolonged hypoxia.
Brain Res.
720:
1-6,
1996[Medline].
23.
LaManna, J. C.,
L. M. Vendel,
and
R. M. Farrell.
Brain adaptation to chronic hypobaric hypoxia in rats.
J. Appl. Physiol.
72:
2238-2243,
1992[Abstract/Free Full Text].
24.
Lauro, K. L.,
and
J. C. LaManna.
Adequacy of cerebral vascular remodeling following three weeks of hypobaric hypoxia. Examined by an integrated composite analytical model.
Adv. Exp. Med. Biol.
411:
369-376,
1997[Medline].
25.
Lutz, P. L.
Mechanisms for anoxic survival in the anoxic vertebrate brain.
Annu. Rev. Physiol.
54:
619-637,
1992[Medline].
26.
Matheson, G. O.,
P. S. Allen,
D. C. Ellinger,
C. C. Hanstock,
D. Gheorghiu,
D. C. McKenzie,
C. Stanley,
W. S. Parkhouse,
and
P. W. Hochachka.
Skeletal muscle metabolism and work capacity: a 31P-NMR study of Andean natives and lowlanders.
J. Appl. Physiol.
70:
1963-1976,
1991[Abstract/Free Full Text].
27.
Miyaoka, M.,
M. Shinohara,
C. Kennedy,
and
L. Sokoloff.
Alterations in local cerebral glucose utilization (LCGU) in rat brain during hypoxemia.
Trans. Am. Neurol. Assoc.
104:
151-154,
1979[Medline].
28.
Monge, C.,
A. Arregui,
and
F. Leon-Velarde.
Pathophysiology and epidemiology of chronic mountain sickness.
Int. J. Sports Med.
13:
S79-S81,
1992.
29.
Monge, C.,
D. Bonavia,
F. Leon-Velarde,
and
A. Arreguis.
High altitude populations in Nepal and the Andes.
In: Hypoxia
The Adaptations, edited by J. R. Sutton,
G. Coates,
and J. E. Remmers. Philadelphia, PA: Decker, 1990, p. 53-58.
30.
Petersen, S. E.,
M. Van Hanneke,
J. A. Fiez,
and
M. E. Raichle.
The effects of practice on the functional anatomy of task performance.
Proc. Natl. Acad. Sci. USA
95:
853-860,
1998[Abstract/Free Full Text].
31.
Phelps, M. E.,
S. E. Huang,
E. J. Hoffman,
C. Selin,
L. Sokoloff,
and
D. E. Kuhl.
Tomographic measurement of local cerebral glucose metabolic rate in humans with (f-18) 2-fluoro-2-deoxy-D-glucose: validation of method.
Ann. Neurol.
6:
371-388,
1979[Medline].
32.
Sick, T. J.,
M. Perez-Pinon,
P. L. Lutz,
and
M. Rosenthal.
Maintaining coupled metabolism and membrane function in anoxic brain: a comparison between the turtle and rat.
In: Surviving Hypoxia, edited by P. W. Hochachka,
P. L. Lutz,
T. Sick,
M. Rosenthal,
and G. Van Den Thillart. Boca Raton, FL: CRC, 1993, p. 351-363.
33.
Sokoloff, L.,
M. Reivich,
C. Kennedy,
M. H. des Rosiers,
C. S. Patlak,
K. D. Pettigrew,
O. Sakurada,
and
M. Shinohara.
The 14C deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anaesthetized albino rat.
J. Neurochem.
28:
897-916,
1977[Medline].
34.
Stapleton, J. M.,
M. J. Morgan,
X. Liu,
B. C. K. Yung,
R. I. Phillips,
D. F. Wong,
E. K. Shayn,
R. F. Dannals,
and
E. D. London.
Cerebral glucose utilization is reduced in second test session.
J. Cereb. Blood Flow Metab.
17:
704-712,
1997[Medline].
35.
Stewart, P. A.,
H. Isaacs,
J. C. LaManna,
and
S. I. Harik.
Ultrastructural concomitants of hypoxia-induced angiogenesis.
Acta Neuropathol. (Berl.)
93:
579-584,
1997[Medline].
36.
Townes, B. D.,
T. F. Hornbein,
R. B. Schoene,
F. H. Sarnquist,
and
I. Grant.
Human cerebral function at extreme altitude.
In: High Altitude and Man, edited by J. B. West,
and S. Lahiri. Bethesda, MD: Am. Physiol. Soc., 1984, p. 31-36.
Am J Physiol Regul Integr Compar Physiol 277(1):R314-R319
0002-9513/99 $5.00
Copyright © 1999 the American Physiological Society